Translating Domestic CAR-T Innovation Into Global Competitiveness: Insights From Korea’s First BLA Approval

• Unveiling the process and strategy in obtaining first domestic CAR-T therapy in Korea
• Sharing the commercialization and expansion plan for approved CAR-T therapy
• Outlining future development plans

Speakers:

Gena Lee Meyers

Business Development Lead

Curocell